Literature DB >> 23104260

Spontaneous improvement of chronic immune thrombocytopenia in children: experience of 56 patients at a single institute.

Motohiro Kato1, Katsuyoshi Koh, Akira Kikuchi, Ryoji Hanada.   

Abstract

Spontaneous improvement (SI) occurs more frequently in children with chronic immune thrombocytopenia (cITP) than in adults. It is generally accepted that, with the exception of splenectomy, conventional medical approaches for cITP do not change the natural course of the disease. Previous studies on pediatric cITP have reported prognostic factors associated with SI; however, it is important to know when such improvement occurs to enable optimal treatment strategies for cITP. Here, we report results of retrospective analysis of 56 consecutive pediatric patients with cITP at our institution. The median follow-up period after ITP diagnosis was 67 months (11-185 months). Of the 44 patients without splenectomy, 17 achieved SI at a median age of 8.5 years (2.3-16.5 years). The estimated incidence of SI was 24.6 ± 6.0 % at 36 months. In 16 of the 17 patients with SI, the recovery was achieved within 18 months from diagnosis, or at an age of less than 10 years, whereas among the 24 who did not achieve spontaneous improvement both at "an age of 10 years or more" and at "18 months or more from ITP diagnosis", only one recovered spontaneously. A treatment decision tree, including the indication for splenectomy, should be considered based on this watershed point.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23104260     DOI: 10.1007/s12185-012-1211-x

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  21 in total

Review 1.  The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia.

Authors:  Cindy Neunert; Wendy Lim; Mark Crowther; Alan Cohen; Lawrence Solberg; Mark A Crowther
Journal:  Blood       Date:  2011-02-16       Impact factor: 22.113

Review 2.  Immune thrombocytopenia.

Authors:  Adam Cuker; Douglas B Cines
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2010

3.  Duration and morbidity of chronic immune thrombocytopenic purpura in children: five-year follow-up of a Nordic cohort.

Authors:  Steen Rosthøj; Jukka Rajantie; Iris Treutiger; Bernward Zeller; Ulf Tedgård; Jan-Inge Henter
Journal:  Acta Paediatr       Date:  2012-05-04       Impact factor: 2.299

4.  Childhood ITP: 12 months follow-up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS).

Authors:  P Imbach; T Kühne; D Müller; W Berchtold; S Zimmerman; M Elalfy; G R Buchanan
Journal:  Pediatr Blood Cancer       Date:  2006-03       Impact factor: 3.167

5.  Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura.

Authors:  Carolyn M Bennett; Zora R Rogers; Daniel D Kinnamon; James B Bussel; Donald H Mahoney; Thomas C Abshire; Hadi Sawaf; Theodore B Moore; Mignon L Loh; Bertil E Glader; Maggie C McCarthy; Brigitta U Mueller; Thomas A Olson; Adonis N Lorenzana; William C Mentzer; George R Buchanan; Henry A Feldman; Ellis J Neufeld
Journal:  Blood       Date:  2005-12-13       Impact factor: 22.113

6.  Predictors of chronic idiopathic thrombocytopenic purpura.

Authors:  Mohssen ElAlfy; Samar Farid; Abeer Abdel Maksoud
Journal:  Pediatr Blood Cancer       Date:  2010-07-01       Impact factor: 3.167

7.  Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial.

Authors:  James B Bussel; Drew Provan; Tahir Shamsi; Gregory Cheng; Bethan Psaila; Lidia Kovaleva; Abdulgabar Salama; Julian M Jenkins; Debasish Roychowdhury; Bhabita Mayer; Nicole Stone; Michael Arning
Journal:  Lancet       Date:  2009-02-21       Impact factor: 79.321

8.  Characterization of chronic idiopathic thrombocytopenic purpura in Japanese children: a retrospective multi-center study.

Authors:  Masaru Kubota; Souichi Adachi; Ikuya Usami; Masayuki Okada; Toshiyuki Kitoh; Mitsutaka Shiota; Yoshihiro Taniguchi; Akihiko Tanizawa; Mitsuhiko Nanbu; Keigo Hamahata; Hisanori Fujino; Kousaku Matsubara; Yoshihiro Wakazono; Tatsutoshi Nakahata
Journal:  Int J Hematol       Date:  2010-01-05       Impact factor: 2.490

9.  Long-term salvage treatment by cyclosporin in refractory autoimmune haematological disorders.

Authors:  G Emilia; C Messora; G Longo; M Bertesi
Journal:  Br J Haematol       Date:  1996-05       Impact factor: 6.998

10.  A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group.

Authors:  Thomas Kühne; George R Buchanan; Sherri Zimmerman; Lisa A Michaels; Regina Kohan; Willi Berchtold; Paul Imbach
Journal:  J Pediatr       Date:  2003-11       Impact factor: 4.406

View more
  1 in total

1.  Natural course of childhood chronic immune thrombocytopenia using the revised terminology and definitions of the international working group: a single center experience.

Authors:  Ye Jee Shim; Uk Hyun Kim; Jin Kyung Suh; Kun Soo Lee
Journal:  Blood Res       Date:  2014-09-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.